It’s been acknowledged that the pharmaceutical industry is a leading contributor to greenhouse gas emissions, even higher than the automotive industry. In response, drug makers are setting aggressive sustainability goals and looking to suppliers to jointly combat this immediate and urgent problem.
Corning is committed to pharmaceutical packaging that supports the industry’s aggressive net-zero emissions initiatives. From sustainable innovations in product design, to material reductions that lessen landfill waste, and supply chain optimizations, Corning pharmaceutical packaging decreases the amount of glass and energy used to make a safe and effective parenteral vial. Material reduction results in using less energy and natural gas in the manufacturing process, as well as a reduction in scope 1, 2, and 3 emissions during production.
Pharma packaging like Corning® Viridian™ Vials feature a low-friction external coating, which preserves strength and can improve filling line efficiency, increasing production in a more environmentally friendly fashion. Please join us for this webinar to learn more about new glass vial options that combine performance and sustainability to help pave the way to a greener future.
You will learn about an innovative glass vial option that combines performance with sustainability and how implementing a sustainable primary packaging solution will benefit scope 3 emission reduction.
Register for free to get video access
Jessica Buday
Strategic Accounts & North America Sales Director at Corning Incorporated
Jessica Buday is the Strategic Accounts & North America Sales Director at Corning Incorporated. She holds a BS in Biochemical Engineering, and has worked for the last 15 years in the pharmaceutical industry, supporting technical, regulatory and quality aspects of sterile injectable manufacturing.